A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit, Biofrontera ...
Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent’s manufacturer. Cemiplimab (Libtayo, Regeneron Pharmaceutica ...
Full House’s Dave Coulier shared how he’s been adjusting to the side effects of chemotherapy treatment amid his battle with stage 3 Non-Hodgkin’s lymphoma.
Calidi Biotherapeutics, a clinical-stage biotechnology company, disclosed on January 8, 2025, its entry into a Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. The agreement pertains to ...